Aetna and Humana Defend Merger, as Antitrust Trial Begins
The Justice Department and proposed merger partners Aetna Inc. and Humana Inc. presented a judge Monday with starkly different visions of how the transaction would affect the marketplace. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 6, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Senate Clears Path for Bill to Speed FDA Drug Approvals
The Senate Monday cleared the final hurdle to passage of broad legislation aimed at boosting federal funds for biomedical research and speeding up government approval of drug and medical-devices. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 6, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Mumps Outbreaks Are Worst in a Decade
The number of mumps cases has nearly tripled in 2016, making it the worst year for outbreaks in a decade. Despite widespread vaccination requirements, college campuses are bearing the brunt of the attack. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 5, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Nerve Treatment When Drugs Fail
To help migraines, rheumatoid arthritis and other conditions, scientists try stimulating the vagus nerve, the same part of the nervous system activated by breathing exercise during meditation. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 5, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Bloomberg Expands Effort to Curb Tobacco Use World-wide
Former New York City mayor and billionaire philanthropist Michael Bloomberg has spent hundreds of millions of dollars of his fortune over the past decade fighting tobacco use in the developing world. Now, with cigarette use declining globally, he is deepening his campaign. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 5, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
FDA Presses Hospitals on Medical-Device Problems
The U.S. Food and Drug Administration is pushing hospitals to do a better job reporting medical-device problems after finding many lapses, including failures to flag a hysterectomy device ’s potentially deadly risk. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 3, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Valeant's Discussions to Sell Salix to Takeda Have Broken Down
Valeant ’s talks to sell a stomach-drug business to Japan’s Takeda Pharmaceutical for roughly $10 billion have broken down. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 1, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
House Passes Bill to Speed Drug Approvals, Boost Medical Research
The House passed far-reaching legislation aimed at bolstering federal funds for biomedical research and speeding up drug and medical-device approvals, a goal long sought by the pharmaceutical industry. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 1, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Getting a New Health Law Through Senate Will Be a Test
Republicans on Capitol Hill are grappling with the likelihood that they will need Democratic support to pass parts of any plan replacing the Affordable Care Act, setting up a complex legislative battle over the law ’s future. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 30, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Trump Signals Big Health Policy Changes Are Coming
In tapping Rep. Tom Price and Medicaid consultant Seema Verma for top health positions, President-elect Donald Trump is signaling that he intends to put conservative health-policy goals at the forefront of his administration. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 30, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Sanofi Drug-Development Partnership Passes First Test
Sanofi SA has received its first set of drug compounds from its collaboration with a Harvard University scientist and his venture backers that aims to jumpstart discovery of new medicines. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 30, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows
Novo Nordisk said its new insulin Tresiba carries about the same risk of serious heart problems as Sanofi ’s Lantus but offers significantly lower risk of dangerously low blood sugar in people with Type-2 diabetes. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 30, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news
Anthem Begins Defense of Cigna Merger at Antitrust Trial
Anthem Inc. executives told a judge that consumers would benefit from the company ’s proposed acquisition of Cigna Corp., saying the new company would be innovative while not reducing competition in the marketplace. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 29, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
DEA Bans a Cousin of Deadly Synthetic Opioid Fentanyl
The Drug Enforcement Administration added furanyl fentanyl, a deadly cousin of the synthetic opioid fentanyl, to its most restrictive list of controlled substances. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 29, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
Marlboro Black Lures Back Millennial Smokers
A slide in the share of young adult smokers who choose Marlboro cigarettes has been arrested by Philip Morris ’s introduction of a lower-priced alternative to its traditional Reds. (Source: WSJ.com: Health)
Source: WSJ.com: Health - November 29, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news
